Inventor
BALDWIN JOHN J
225 patents
⚠️ This page may combine multiple inventors who share the name “BALDWIN JOHN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
28 patentsUS5633247AMay 27, 1997
Nitrogen-containing spirocycles
MERCK & CO INC73 citations96
US5595990AJan 21, 1997
Antiarrhythmic benzodiazepines
MERCK & CO INC61 citations96
US5215989AJun 1, 1993
Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
MERCK & CO INC108 citations96
US5206240AApr 27, 1993
Nitrogen-containing spirocycles
MERCK & CO INC77 citations96
US5032598AJul 16, 1991
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
MERCK & CO INC58 citations96
US5030644AJul 9, 1991
Imidazole compounds and their use as transglutaminase inhibitors
MERCK & CO INC72 citations96
US4797413AJan 10, 1989
Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
MERCK & CO INC103 citations96
US4358455ANov 9, 1982
Aralkylamindethanol heterocyclic compounds
MERCK & CO INC59 citations96
US4058614ANov 15, 1977
Substituted imidazole compounds and therapeutic compositions therewith
MERCK & CO INC77 citations96
US5475109ADec 12, 1995
Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
MERCK & CO INC56 citations95
US4735956AApr 5, 1988
Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
MERCK & CO INC53 citations95
US6316443B1Nov 13, 2001
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
MERCK & CO INC20 citations93
US5098707AMar 24, 1992
Imidazole compounds and their use as transglutaminase inhibitors
MERCK & CO INC29 citations93
US4656188AApr 7, 1987
Ace inhibitors in macular degeneration
MERCK & CO INC25 citations93
US5439906AAug 8, 1995
Antiarrhythmic benzodiazepines
MERCK & CO INC24 citations92
US5426185AJun 20, 1995
Antiarrhythmic benzodiazepines
MERCK & CO INC21 citations92
US5112824AMay 12, 1992
Benzofuran compounds as class III antiarrhythmic agents
MERCK & CO INC25 citations92
US4863922ASep 5, 1989
Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
MERCK & CO INC52 citations92
US4675321AJun 23, 1987
Substituted pyrimidines useful as calcium channel blockers
MERCK & CO INC30 citations92
US4602093AJul 22, 1986
Novel substituted imidazoles, their preparation and use
MERCK & CO INC34 citations92
US5821241AOct 13, 1998
Fibrinogen receptor antagonists
MERCK & CO INC21 citations89
US6248735B1Jun 19, 2001
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
MERCK & CO INC17 citations84
US4996321AFeb 26, 1991
Dibenzo[a,d]cycloheptenylidene compounds
MERCK & CO INC19 citations82
US4871739AOct 3, 1989
Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
MERCK & CO INC22 citations82
US4677115AJun 30, 1987
Antiglaucoma thieno-thiopyran and thieno-thiepin sulfonamide derivatives, compositions, and method of use thereof
MERCK & CO INC24 citations82
US4656168AApr 7, 1987
(3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
MERCK & CO INC24 citations82
US4442094AApr 10, 1984
(3-Aralkylamino-2-or-propoxy)heterocyclic compounds
MERCK & CO INC19 citations82
US4408047AOct 4, 1983
Imidazodiazines
MERCK & CO INC22 citations82
SCHERING CORP
9 patentsUS6432959B1Aug 13, 2002
Inhibitors of farnesyl-protein transferase
SCHERING CORP75 citations96
US5801175ASep 1, 1998
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP68 citations96
US5880128AMar 9, 1999
Carbonyl piperazinyl and piperidinyl compounds
SCHERING CORP77 citations94
US6878709B2Apr 12, 2005
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
SCHERING CORP20 citations92
US6849621B2Feb 1, 2005
Piperidine compounds
SCHERING CORP39 citations92
US6214827B1Apr 10, 2001
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US7868005B2Jan 11, 2011
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP9 citations83
US7964646B2Jun 21, 2011
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
US7947720B2May 24, 2011
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
SCHERING CORP10 citations82
PHARMACOPEIA INC
7 patentsUS5618825AApr 8, 1997
Combinatorial sulfonamide library
PHARMACOPEIA INC73 citations96
US5821130AOct 13, 1998
Combinatorial dihydrobenzopyran library
PHARMACOPEIA INC56 citations95
US5688997ANov 18, 1997
Process for preparing intermediates for a combinatorial dihydrobenzopyran library
PHARMACOPEIA INC70 citations95
US5663046ASep 2, 1997
Synthesis of combinatorial libraries
PHARMACOPEIA INC89 citations95
US5766963AJun 16, 1998
Combination hydroxypropylamine library
PHARMACOPEIA INC73 citations94
US6017768AJan 25, 2000
Combinatorial dihydrobenzopyran library
PHARMACOPEIA INC52 citations92
US7479495B2Jan 20, 2009
N-heterocyclic inhibitors of TNF-α expression
PHARMACOPEIA INC11 citations83
PHARMACOPEIA DRUG DISCOVERY
2 patentsVITAE PHARMACEUTICALS INC
2 patentsBERLEX LAB
1 patentPHARMACEOPEIA INC
1 patentShowing the top 50 of 225 patents by PatentIndex Score.